Dr. Alina Kifayat, MBBS
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,282 | 126 | 97.1% |
| Education | $99.00 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $839.51 | 18 | $0 (2024) |
| Amgen Inc. | $454.10 | 17 | $0 (2024) |
| Lilly USA, LLC | $334.61 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $216.65 | 10 | $0 (2024) |
| UCB, Inc. | $188.88 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $175.60 | 5 | $0 (2024) |
| Novo Nordisk Inc | $163.37 | 8 | $0 (2024) |
| Boston Scientific Corporation | $146.08 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $120.27 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $104.41 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,426 | 54 | ABBVIE INC. ($400.82) |
| 2023 | $1,852 | 67 | ABBVIE INC. ($438.69) |
| 2022 | $103.45 | 6 | Novo Nordisk Inc ($24.76) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Immunology | ||||||
| 06/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Analgesic | ||||||
| 05/29/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Bone Health | ||||||
| 05/14/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Inflammation | ||||||
| 05/10/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Sports Early Intervention | ||||||
| 05/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
| 04/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/22/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ENDOCRINE AGENT | ||||||
| 04/12/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: GI COLON PREP | ||||||
| 04/04/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Immunology | ||||||
| 03/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Endocrinology | ||||||
| 03/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Obesity | ||||||
| 03/13/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 01/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 257 | 399 | $103,135 | $40,083 |
| 2022 | 3 | 52 | 59 | $19,865 | $8,536 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 193 | $46,320 | $19,993 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $33,215 | $11,881 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,280 | $2,994 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 20 | $6,500 | $2,944 | 45.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 34 | $8,200 | $1,954 | 23.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 18 | 19 | $380.00 | $174.94 | 46.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 24 | $240.00 | $142.14 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,665 | $3,092 | 40.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $6,440 | $2,723 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 24 | $5,760 | $2,721 | 47.2% |
About Dr. Alina Kifayat, MBBS
Dr. Alina Kifayat, MBBS is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1689029357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alina Kifayat, MBBS has received a total of $3,381 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 127 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,282).
As a Medicare-enrolled provider, Kifayat has provided services to 309 Medicare beneficiaries, totaling 458 services with total Medicare billing of $48,620. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Rheumatology
- Location Valhalla, NY
- Active Since 04/29/2016
- Last Updated 09/07/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1689029357
Products in Payments
- VRAYLAR (Drug) $625.00
- Otezla (Drug) $313.51
- TALTZ (Drug) $252.89
- TREMFYA (Drug) $175.60
- Cimzia (Drug) $169.84
- WATCHMAN FLX (Device) $146.08
- TRELEGY ELLIPTA (Drug) $137.17
- ACTHAR (Biological) $120.27
- RINVOQ (Biological) $107.75
- Kerendia (Drug) $104.41
- MINIMED 780G (Device) $86.27
- AREXVY (Drug) $79.48
- Rybelsus (Drug) $74.46
- EVENITY (Biological) $72.61
- SKYRIZI (Biological) $71.53
- Ozempic (Drug) $57.63
- JARDIANCE (Drug) $49.02
- XELJANZ (Drug) $47.15
- TRINTELLIX (Drug) $46.38
- XIFAXAN (Drug) $41.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Valhalla
Eitan Glucksman, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,301
Jasnit Makkar, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,870
Dr. Tasleem Katchi, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $7,795
Dr. Logan Carr, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,431
Dr. Gabriel Froula, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $4,560
Dr. Ethan Paulin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,429